Cash in bank has improved with receipts from the BCD going to a number of customers.
Hopefully it's used to build the promised FBN (Flash Back Needle) which would be sold with the existing BCD (Blood Collection Device).
Still no interest from buyers.
Perhaps an announcement, a real announcement and not a financial statement might defib the share price in the right direction.
